KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xenon Pharmaceuticals (XENE) Preferred Dividend Payments: 2013-2022

Historic Preferred Dividend Payments for Xenon Pharmaceuticals (XENE) over the last 6 years, with Dec 2022 value amounting to $437,000.

  • Xenon Pharmaceuticals' Preferred Dividend Payments fell 96.51% to $17,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $119,000, marking a year-over-year decrease of 93.36%. This contributed to the annual value of $437,000 for FY2022, which is 75.65% down from last year.
  • Per Xenon Pharmaceuticals' latest filing, its Preferred Dividend Payments stood at $437,000 for FY2022, which was down 75.65% from $1.8 million recorded in FY2021.
  • In the past 5 years, Xenon Pharmaceuticals' Preferred Dividend Payments registered a high of $2.9 million during FY2018, and its lowest value of $437,000 during FY2022.
  • Moreover, its 3-year median value for Preferred Dividend Payments was $824,000 (2020), whereas its average is $1.0 million.
  • As far as peak fluctuations go, Xenon Pharmaceuticals' Preferred Dividend Payments surged by 117.84% in 2021, and later plummeted by 75.65% in 2022.
  • Yearly analysis of 5 years shows Xenon Pharmaceuticals' Preferred Dividend Payments stood at $2.9 million in 2018, then slumped by 45.57% to $1.6 million in 2019, then plummeted by 47.45% to $824,000 in 2020, then surged by 117.84% to $1.8 million in 2021, then slumped by 75.65% to $437,000 in 2022.